Cano Health, Inc. (NYSE:CANO) Receives Consensus Rating of “Reduce” from Brokerages

Cano Health, Inc. (NYSE:CANO – Get Free Report) has received an average rating of “Reduce” from the five analysts that are currently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating and four have given a hold rating to the company. The average 1 year target […]

Leave a Reply

Your email address will not be published.

Previous post Manhattan Bridge Capital (NASDAQ:LOAN) Stock Rating Upgraded by StockNews.com
Next post Analysts Set Cushman & Wakefield plc (NYSE:CWK) Price Target at $10.30